APPARENT GENETIC DIFFERENCE BETWEEN HYPOTHYROID PATIENTS WITH BLOCKING-TYPE THYROTROPIN RECEPTOR ANTIBODY AND THOSE WITHOUT, AS SHOWN BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSES OF HLA-DP LOCI

被引:21
作者
INOUE, D
SATO, K
SUGAWA, H
AKAMIZU, T
MAEDA, M
INOKO, H
TSUJI, K
MORI, T
机构
[1] NICHIREI CORP, RES INST, TOKYO, JAPAN
[2] KYOTO UNIV, SCH MED, DEPT LAB MED, KYOTO 606, JAPAN
[3] KYOTO UNIV, SCH MED, DIV INTERNAL MED 2, KYOTO 606, JAPAN
[4] TOKAI UNIV, SCH MED, DEPT TRANSPLANTA, KANAGAWA, JAPAN
关键词
D O I
10.1210/jc.77.3.606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HLA types in Japanese patients with primary hypothyroidism were analyzed to see whether those with blocking-type TSH receptor antibody (TSH-R BAb M) differed genetically from those with idiopathic myxedema (IM). HLA typings of -A, -B, -C, -DR, and -DQ (73 antigens) were performed serologically, and those of -D and -DP (29 antigens) were analyzed by the restriction fragment length polymorphism method. Thirty patients were studied with TSH-R BAb M, and 28 with IM. The data were analyzed and compared with our previous results from 88 Graves' patients, 46 Hashimoto patients, and 186 control subjects. Overall, 192 patients with 4 autoimmune thyroid disorders showed a decrease in -Aw19 and an increase in -DQw4 (corrected P < 0.05) and significant associations of -Aw33, -Bw46, -Cw3, -DRw8, -DR9, and -DQw3. In TSH-R BAb M patients, increases in -B35, -Bw60, and -Dw8 and decreases in -DR4 and -DPw2 were seen, whereas IM patients showed increased -DPw2, -Bw61, and -Dw23. In comparisons between TSH-R BAb M and IM, the difference in -DPw2 was highly significant. HLA-B35 differed significantly in these 2 types of hypothyroidism. In conclusion, TSH-R BAb M patients have decreased frequency of -DPw2 and are genetically similar to Graves' disease, whereas IM patients are characterized by high frequency of -DPw2 and are genetically similar to Hashimoto's thyroiditis.
引用
收藏
页码:606 / 610
页数:5
相关论文
共 30 条
[1]   ABNORMAL THYROTROPIN-BINDING IMMUNOGLOBULINS IN 2 PATIENTS WITH GRAVES-DISEASE [J].
AKAMIZU, T ;
ISHII, H ;
MORI, T ;
ISHIHARA, T ;
IKEKUBO, K ;
IMURA, H ;
BITO, S ;
SAIKI, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (02) :240-245
[2]   INVITRO CONVERSION OF BLOCKING TYPE ANTI-TSH RECEPTOR ANTIBODY TO THE STIMULATING TYPE BY ANTI-HUMAN IGG ANTIBODIES [J].
AMINO, N ;
WATANABE, Y ;
TAMAKI, H ;
IWATANI, Y ;
MIYAI, K .
CLINICAL ENDOCRINOLOGY, 1987, 27 (05) :615-624
[3]   SUSCEPTIBILITY TO THYROID AUTOIMMUNE-DISEASE - MOLECULAR ANALYSIS OF HLA-D REGION GENES IDENTIFIES NEW MARKERS FOR GOITROUS HASHIMOTOS-THYROIDITIS [J].
BADENHOOP, K ;
SCHWARZ, G ;
WALFISH, PG ;
DRUMMOND, V ;
USADEL, KH ;
BOTTAZZO, GF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (05) :1131-1137
[4]   SERUM THYROTROPHIN IN MYXEDEMA AND IN ASYMPTOMATIC ATROPHIC THYROIDITIS [J].
BONNYNS, M ;
BASTENIE, PA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (06) :849-+
[5]   THYROID GROWTH-BLOCKING ANTIBODIES IN PRIMARY MYXEDEMA [J].
DREXHAGE, HA ;
BOTTAZZO, GF ;
BITENSKY, L ;
CHAYEN, J ;
DONIACH, D .
NATURE, 1981, 289 (5798) :594-596
[6]   DETECTION AND PROPERTIES OF TSH-BINDING INHIBITOR IMMUNOGLOBULINS IN PATIENTS WITH GRAVES-DISEASE AND HASHIMOTO THYROIDITIS [J].
ENDO, K ;
KASAGI, K ;
KONISHI, J ;
IKEKUBO, K ;
OKUNO, T ;
TAKEDA, Y ;
MORI, T ;
TORIZUKA, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (05) :734-739
[7]  
FARID NR, 1986, MOL BIOL MED, V3, P85
[8]  
FARID NR, 1981, TISSUE ANTIGENS, V17, P265
[9]   STRONG ASSOCIATION BETWEEN HLA DRW9 AND HASHIMOTOS-THYROIDITIS IN SOUTHERN CHINESE [J].
HAWKINS, BR ;
LAM, KSL ;
MA, JTC ;
WANG, C ;
YEUNG, RTT .
ACTA ENDOCRINOLOGICA, 1987, 114 (04) :543-546
[10]   HASHIMOTO THYROIDITIS AND HLA IN JAPANESE [J].
HONDA, K ;
TAMAI, H ;
MORITA, T ;
KUMA, K ;
NISHIMURA, Y ;
SASAZUKI, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (06) :1268-1273